Mismatch repair genes hMLH1 and hMSH2 may not play an essential role in breast carcinogenesis

International Journal of Surgical Pathology

Volumn 15, Issue 3, 2007, Pages 233-241

  Khilko, Natalya ^a   Bourne, Patricia ^a   Yang, Qi ^a   Tang, Ping ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Ductal carcinoma in situ; HMLH1; hMSH2; Invasive ductal carcinoma; MSI

Indexed keywords

CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CLINICAL FEATURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MISMATCH REPAIR; PRIORITY JOURNAL; TUMOR VOLUME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA MISMATCH REPAIR; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINS; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 34250885848     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896907302116     Document Type: Article

References (71)

1. Duval A., Hamelin R. Genetic instability in human mismatch repair deficient cancers. Ann Genet. 2002 ; 45: 71-75.
2. Thibodeau SN, Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993 ; 260: 816-819.
3. Liu B., Nicolaides NC, Markowitz S., et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet. 1995 ; 9: 48-55.
4. Soreide K., Janssen Eam, Soiland H., et al. Microsatellite instability in colorectal cancer. Br J Surg. 2006 ; 93: 395-406.
5. Halling KC, Harper J., Moskaluk CA, et al. Origin of microsatellite instability in gastric cancer. Am J Pathol. 1999 ; 155: 205-211.
6. Ottini L., Falchetti M., Lupi R., et al. Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol. 2006 ; 17 (suppl 7). vii97 - vii102.
7. Burks RT, Kessis TD, Cho KR, et al. Microsatellite instability in endometrial carcinoma. Oncogene. 1994 ; 9: 1163-1166.
8. Geisler JP, Goodheart MJ, Sood AK, et al. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer. 2003 ; 98: 2199-2206.
9. Cai KQ, Albarracin C., Rosen D., et al. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum Pathol. 2004 ; 35: 552-559.
10. Chagpar A., Magliocco A., Kerviche A., et al. The replication error phenotype is associated with the development of distant metastases in hormonally treated patients with breast carcinoma. Cancer. 2004 ; 100: 913-919.
11. Yee CJ, Roodi N., Verrier CS, Parl FF Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res. 1994 ; 54: 1641-1644.
12. Contegiacomo A., Palmirotta R., De Marchis L, et al. Microsatellite instability and pathological aspects of breast cancer. Int J Cancer. 1995 ; 64: 264-268.
13. Shaw JA, Walsh T., Chappell SA, et al. Microsatellite instability in early sporadic breast cancer. Br J Cancer. 1996 ; 73: 1393-1397.
14. Toyama T., Iwase H., Iwata H., et al. Microsatellite instability in in situ and invasive sporadic breast cancers of Japanese women. Cancer Lett. 1996 ; 108: 205-209.
15. Shen KL, Yang LS, Hsieh HF, et al. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity. J Surg Oncol. 2000 ; 74: 100-107.
16. Aldaz CM, Chen T., Sahin A., et al. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinoma. Cancer Res. 1995 ; 55: 3976-3981.
17. Pizzi C., Panico L., De Marchis L, et al. p53 expression is decreased in primary breast carcinomas with microsatellite instability. Breast Cancer Res Treat. 2002 ; 73: 257-266.
18. De Marchis L, Contegiacomo A., D'Amico C., et al. Microsatellite instability is correlated with lymph node-positive breast cancer. Clin Cancer Res. 1997 ; 3: 241-248.
19. Paulson TG, Wright FA, Parker BA, et al. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res. 1996 ; 56: 4021-4026.
20. Luqmani YA, Mathew M., Lobo S. Frequent microsatellite alterations in a predominantly younger age of onset breast cancer population. Int J Mol Med. 2003 ; 11: 117-124.
21. Bock N., Meden H., Regenbrecht M., et al. Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast. Anticancer Res. 2000 ; 20: 119-124.
22. Son BH, Ahn SH, Ko CD, et al. Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast. Breast J. 2004 ; 10: 20-26.
23. Lothe AR, Peltomaki P., Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 1993 ; 53: 5849-5852.
24. Peltomaki P., Lothe AR, Aaltonen LA, et al. Microsatellite instability is associated with tumours that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 1993 ; 53: 5853-5855.
25. Anbazhagan R., Fujii H., Gabrieison E. Microsatellite instability is uncommon in breast cancer. Clin Cancer Res. 1999 ; 5: 839-844.
26. Orlandi F., Barucca A., Biagini G., et al. Molecular stability of DNA typing short tandem repeats in the mammary tree of patients with breast cancer. Diagn Mol Pathol. 2002 ; 11: 41-46.
27. Molist R., Remyikos Y., Dutrillaux B., Muleris M. Characterization of a new cytogenetic subtype of ductal breast carcinomas. Oncogene. 2004 ; 23: 5986-5993.
28. Ozer E., Yuksel E., Kizildag S., et al. Microsatellite instability in early-onset breast cancer. Pathol Res Pract. 2002 ; 198: 525-530.
29. Batistatou A., Arkoumani E., Stefanou D. Expression of mismatch repair proteins in invasive and in situ carcinoma of the breast. In V ivo 2004 ;18: 661-666.
30. Debniak T., Kurzawski G., Gorski B., et al. Value of pedigree/ clinical data, Immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer. 2000 ; 36: 49-54.
31. Marcus VA, Madlensky L., Gryfe R., et al. Immunohistochemistry for hMLH and hMSH2: A practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol. 1999 ; 23: 1248-1255.
32. Chaves P., Cruz C., Lage P., et al. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for identification of colorectal carcinoma with the mutator phenotype. J Pathol. 2000 ; 191: 355-360.
33. Lindor NM, Burgart LJ, Leontovich O., et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002 ; 20: 1043-1048.
34. Hatch SB, Lightfoot HM Jr, Garwacki CP, et al. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors. Clin Cancer Res. 2005 ; 11: 2180-2187.
35. Rigau V., Sebbagh N., Oslchwang S., et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role of hMLH6 immunostaining. Arch Pathol Lab Med. 2003 ; 127: 694-700.
36. Boecker W., Moll R., Dervan P., et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol. 2002 ; 198: 458-467.
37. Van de Rijn M., Perou CM, Tibshirani R., et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002 ; 161: 1991-1996.
38. El-Rehim Dma, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 2004 ; 203: 661-671.
39. Tang P., Wang X., Schiffhauer L., et al. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers. Ann Clin Lab Sci. 2006 ; 36: 17-22.
40. Tang P., Wang X., Schiffhauer L., et al. Expression patterns of ER-a, PR, Her-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ. Ann Clin Lab Sci. 2006 ; 36: 137-143.
41. Steinman S., Wang J., Bourne P., et al. Expression of cytokeratin markers, ER, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC). Ann Clin Lab Sci. 2007 ; 37: 127-134.
42. Han HJ, Yanagisawa A., Koto Y., et al. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res. 1993 ; 53: 5087-5087.
43. Patel U., Grundfest-Briniatowski S., Gupta M., et al. Microstallite instability at five chromosomes in primary breast tumours. Oncogene. 1994 ; 9: 3695-3700.
44. Ellsworth RE, Ellsworth DL, Deyarmin B., et al. Timing of critical changes in human breast disease. Ann Surg Oncol. 2005 ; 12: 1-7.
45. Rosenberg CL, Larson PS, Romo JD, et al. Microsatellite alterations indicating monoclonality in atypical hyperplasia associated with breast cancer. Hum Pathol. 1997 ; 28: 214-219.
46. Sarrio D., Moreno-Bueno G., Hardisson D., et al. Epigenetic and generic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer. 2003 ; 106: 208-215.
47. Caldes T., Perez-Segura P., Tosar A., et al. Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer. Teratog Carcinog Mutagen. 2000 ; 20: 283-291.
48. Dillon EK, de Boer WB, Papadimitriou JM, Turbett GR Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors. Br J Cancer. 1997 ; 76: 156-162.
49. Demokan S., Muslumanoglu M., Yazici H., et al. Investigation of microsatellite instability in Turkish breast cancer patients. Pathol Oncol Res. 2002 ; 8: 138-141.
50. Kaneko M., Arihiro K., Takeshima Y., et al. Loss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast. J Exp Ther Oncol. 2002 ; 2: 9-18.
51. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998 ; 58: 5248-5257.
52. Gologan A., Krasinskas A., Hunt J., et al. Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Arch Pathol Lab Med. 2005 ; 129: 1390-1397.
53. Rodirguse-Bigas MA, Boland CR, Hamilton SR, et al. A. National Cancer Institute Workshop in Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guideline. J Natl Cancer Inst. 1997 ; 89: 1758-1762.
54. Umar A., Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 ; 96: 261-268.
55. Wild PJ, Stoehr R., Knuecher R., et al. Laser microdissection for microsatellite analysis in colon and breast cancer. Methods Mol Biol. 2005 ; 293: 93-101.
56. Sieben NL, ter Haar NT, Cornelisse CJ, et al. PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol. 2000 ; 31: 1414-1419.
57. Siah SP, Quinn DM, Bennett GD, et al. Microsatellite instability in breast cancer: a review and study showing MSI was not detected at "BAT-25" and "AT-26" microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat. 2000 ; 60: 135-142.
58. Pizzi C., Di Maio M., Daniele S., et al. Triple repeat instability correlates with dinucleotide instability in primary breast cancer. Oncol Rep. 2007 ; 17: 193-199.
59. Linder NM, Burgart LJ, Leontovich O., et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumor. J Clin Oncol. 2002 ; 20: 1043-1048.
60. Wild PJ, Reichle A., Andreesen R., et al. Microsatellite instability predicts poor short-term survival in patients with advanced breast cancer after high-dose chemotherapy and autologous stem-cell transplantation. Clin Cancer Res. 2004 ; 10: 556-564.
61. Walsh T., Chappell SA, Shaw JA, Walker RA Microsatellite instability in ductal carcinoma in situ of the breast. J Pathol. 1998 ; 185: 18-24.
62. Spagnoletti I., Pizzi C., Galietta A., et al. Loss of hMSH2 expression in primary breast cancer with p53 alternations. Oncol Rep. 2004 ; 11: 845-851.
63. Murata H., Khattar NH, Gu L., Li GM Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett. 2005 ; 223: 143-150.
64. Ben Yehuda A, Globeson A., Krichevsky S., et al. Ageing and the mismatch repair system. Mech Ageing Dev. 2000 ; 121: 173-179.
65. Schmitt FC, Soares R., Gobbi H., et al. Microsatellite instability in medullary breast carcinomas. Int J Cancer. 1999 ; 82: 644-647.
66. Lee SC, Berg KD, Sherman ME, et al. Microsatellite instability is infrequent in medullary breast cancer. Am J Clin Pathol. 2001 ; 115: 823-827.
67. Osin P., Lu YJ, Stone J., et al. Distinct genetic and epigenetic changes in medullary breast cancer. Int J Surg Pathol. 2003 ; 11: 153-158.
68. Yuksel E., Ozer E., Kizildag S., et al. Microsatellite instability is not a common feature in medullary breast cancer. Breast. 2002 ; 11: 473-477.
69. van der Looij M., Papp J., Sztan M., et al. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors. Int J Oncol. 2001 ; 18: 775-780.
70. Adem C., Soderberg CL, Cunningham JM, et al. Microsatellite instability in hereditary and sporadic breast cancers. Int J Cancer. 2003 ; 107: 580-582.
71. Huiping C., Johannsdottir JT, Arason A., et al. Replication error in human breast cancer: comparison with clinical variables and family history of cancer. Oncol Rep. 1999 ; 6: 117-122.